<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Clark AJ</submitter><funding>Brain Research UK</funding><funding>NINDS NIH HHS</funding><funding>Rosetrees</funding><funding>Wellcome Trust</funding><pagination>100345</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8324498</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(7)</volume><pubmed_abstract>Hereditary sensory neuropathy type 1 (HSN1) is caused by mutations in the &lt;i>SPTLC1&lt;/i> or &lt;i>SPTLC2&lt;/i> sub-units of the enzyme serine palmitoyltransferase, resulting in the production of toxic 1-deoxysphingolipid bases (DSBs). We used induced pluripotent stem cells (iPSCs) from patients with HSN1 to determine whether endogenous DSBs are neurotoxic, patho-mechanisms of toxicity and response to therapy. HSN1 iPSC-derived sensory neurons (iPSCdSNs) endogenously produce neurotoxic DSBs. Complex gangliosides, which are essential for membrane micro-domains and signaling, are reduced, and neurotrophin signaling is impaired, resulting in reduced neurite outgrowth. In HSN1 myelinating cocultures, we find a major disruption of nodal complex proteins after 8 weeks, which leads to complete myelin br</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions.</pubmed_title><pmcid>PMC8324498</pmcid><funding_grant_id>203141/Z/16/Z</funding_grant_id><funding_grant_id>U54 NS065712</funding_grant_id><funding_grant_id>M861</funding_grant_id><funding_grant_id>202747/Z/16/Z</funding_grant_id><funding_grant_id>202834/Z/16/Z</funding_grant_id><funding_grant_id>102645/Z/13/Z</funding_grant_id><funding_grant_id>201718-11</funding_grant_id><pubmed_authors>Fugger N</pubmed_authors><pubmed_authors>Kalmar B</pubmed_authors><pubmed_authors>Kugathasan U</pubmed_authors><pubmed_authors>Bennett DL</pubmed_authors><pubmed_authors>Othman A</pubmed_authors><pubmed_authors>Greensmith L</pubmed_authors><pubmed_authors>Chu KH</pubmed_authors><pubmed_authors>Hornemann T</pubmed_authors><pubmed_authors>Clark AJ</pubmed_authors><pubmed_authors>Reilly MM</pubmed_authors><pubmed_authors>Baskozos G</pubmed_authors><pubmed_authors>Blesneac I</pubmed_authors><pubmed_authors>Laura M</pubmed_authors><pubmed_authors>Lone MA</pubmed_authors><pubmed_authors>Priestman DA</pubmed_authors><pubmed_authors>Platt FM</pubmed_authors><pubmed_authors>Wilson ER</pubmed_authors></additional><is_claimable>false</is_claimable><name>An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions.</name><description>Hereditary sensory neuropathy type 1 (HSN1) is caused by mutations in the &lt;i>SPTLC1&lt;/i> or &lt;i>SPTLC2&lt;/i> sub-units of the enzyme serine palmitoyltransferase, resulting in the production of toxic 1-deoxysphingolipid bases (DSBs). We used induced pluripotent stem cells (iPSCs) from patients with HSN1 to determine whether endogenous DSBs are neurotoxic, patho-mechanisms of toxicity and response to therapy. HSN1 iPSC-derived sensory neurons (iPSCdSNs) endogenously produce neurotoxic DSBs. Complex gangliosides, which are essential for membrane micro-domains and signaling, are reduced, and neurotrophin signaling is impaired, resulting in reduced neurite outgrowth. In HSN1 myelinating cocultures, we find a major disruption of nodal complex proteins after 8 weeks, which leads to complete myelin br</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-08T14:33:17.29Z</modification><creation>2022-02-11T02:18:10.873Z</creation></dates><accession>S-EPMC8324498</accession><cross_references><pubmed>34337561</pubmed><doi>10.1016/j.xcrm.2021.100345</doi></cross_references></HashMap>